Isosorbide dinitrate
Bidil, Ismotic, Isordil, Monoket (isosorbide dinitrate) is a small molecule pharmaceutical. Isosorbide dinitrate was first approved as Ismotic on 1982-01-01. It is used to treat angina pectoris, coronary disease, cyanosis, diffuse esophageal spasm, and gastroesophageal reflux amongst others in the USA.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Isordil, Monoket (generic drugs available since 1987-03-12, discontinued: Dilatrate-sr, Imdur, Ismo, Ismotic, Sorbitrate)
CombinationsBidil (generic drugs available since 1987-03-12)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Hydralazine hydrochloride
+
Isosorbide dinitrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BIDIL | Azurity | N-020727 RX | 2005-06-23 | 1 products, RLD, RS |
Isosorbide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ISMOTIC | Alcon Research | N-017063 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Isosorbide dinitrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ISORDIL | Bausch Health Companies | N-012093 RX | 1988-07-29 | 2 products, RLD |
Show 7 discontinued
Isosorbide mononitrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| MONOKET | ECI Pharmaceuticals | N-020215 RX | 1993-06-30 | 2 products, RLD |
Show 2 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| bidil | New Drug Application | 2022-07-19 |
| ismotic | 2006-03-23 | |
| isordil | New Drug Application | 2019-08-08 |
| isosorbide dinitrate | ANDA | 2023-05-22 |
| isosorbide mononitrate | ANDA | 2022-10-31 |
| monoket | New Drug Application | 2015-02-03 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| angina pectoris | EFO_0003913 | D000787 | I20 |
| coronary disease | — | D003327 | — |
| cyanosis | — | D003490 | R23.0 |
| diffuse esophageal spasm | EFO_1001785 | D015155 | K22.4 |
| gastroesophageal reflux | EFO_0003948 | D005764 | K21 |
| heart failure | EFO_0003144 | D006333 | I50 |
| poisoning | EFO_0008546 | D011041 | T65.91 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
C: Cardiovascular system drugs
— C01: Cardiac therapy drugs
— C01D: Vasodilators used in cardiac diseases
— C01DA: Organic nitrates used in cardiac disease
— C01DA08: Isosorbide dinitrate
— C01DA58: Isosorbide dinitrate, combinations
— C05: Vasoprotectives
— C05A: Agents for treatment of hemorrhoids and anal fissures for topical use
— C05AE: Muscle relaxants for treatment of hemorrhoids and anal fissures for topical use
— C05AE02: Isosorbide dinitrate
HCPCS
No data
Clinical
Clinical Trials
68 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Heart failure | D006333 | EFO_0003144 | I50 | 1 | 2 | 1 | 3 | 1 | 8 |
| Coronary disease | D003327 | — | — | 1 | 2 | 1 | 4 | ||
| Coronary artery disease | D003324 | I25.1 | 1 | — | — | 3 | — | 4 | |
| Portal hypertension | D006975 | EFO_0000666 | K76.6 | — | — | — | 1 | 1 | 2 |
| Unstable angina | D000789 | EFO_1000985 | I20.0 | — | — | — | 1 | — | 1 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.81 | — | — | — | 1 | — | 1 |
| Coronary stenosis | D023921 | EFO_1000882 | — | — | — | 1 | — | 1 | |
| Pre-eclampsia | D011225 | EFO_0000668 | O14 | — | — | — | 1 | — | 1 |
| Premature obstetric labor | D007752 | O60 | — | — | — | 1 | — | 1 | |
| Coronary artery bypass | D001026 | EFO_0003776 | — | — | — | 1 | — | 1 |
Show 6 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cerebral small vessel diseases | D059345 | — | 2 | 1 | — | — | 2 | ||
| Cardio-renal syndrome | D059347 | — | — | 1 | — | 1 | 2 | ||
| Contraception | D003267 | — | — | 1 | — | — | 1 | ||
| Rupture | D012421 | — | — | 1 | — | — | 1 | ||
| Lacunar stroke | D059409 | I63.81 | — | 1 | 1 | — | — | 1 | |
| Diabetic foot | D017719 | EFO_1001459 | — | — | 1 | — | — | 1 | |
| Oligohydramnios | D016104 | EFO_0007401 | O41.0 | — | 1 | 1 | — | — | 1 |
| Stable angina | D060050 | I20.8 | — | — | 1 | — | — | 1 | |
| Left ventricular dysfunction | D018487 | — | — | 1 | — | — | 1 | ||
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | 1 | — | — | 1 |
Show 2 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | 2 | 2 | — | — | — | 4 |
| Cervical ripening | D020070 | — | 1 | — | — | 1 | 2 | ||
| Induced labor | D007751 | 1 | 2 | — | — | — | 2 | ||
| Proteinuria | D011507 | HP_0000093 | R80 | — | 1 | — | — | — | 1 |
| Acute kidney injury | D058186 | HP_0001919 | N17 | — | 1 | — | — | — | 1 |
| Tachycardia | D013610 | HP_0001649 | R00.0 | 1 | 1 | — | — | — | 1 |
| Orthostatic intolerance | D054971 | 1 | 1 | — | — | — | 1 | ||
| Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | — | — | — | 1 |
| Cognitive dysfunction | D060825 | G31.84 | — | 1 | — | — | — | 1 | |
| Missed abortion | D000030 | O02.1 | — | 1 | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Atopic dermatitis | D003876 | EFO_0000274 | L20 | — | — | — | — | 2 | 2 |
| Headache | D006261 | HP_0002315 | R51 | — | — | — | — | 2 | 2 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 1 | 1 |
| Glaucoma | D005901 | EFO_0000516 | H40 | — | — | — | — | 1 | 1 |
| Migraine disorders | D008881 | EFO_0003821 | G43 | — | — | — | — | 1 | 1 |
| Pancreatitis | D010195 | EFO_0000278 | K85 | — | — | — | — | 1 | 1 |
| Acute coronary syndrome | D054058 | EFO_0005672 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | ISOSORBIDE DINITRATE |
| INN | isosorbide dinitrate |
| Description | Isosorbide dinitrate is a nitrate ester and a glucitol derivative. It has a role as a vasodilator agent and a nitric oxide donor. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-] |
Identifiers
| PDB | — |
| CAS-ID | 87-33-2 |
| RxCUI | 6058 |
| ChEMBL ID | CHEMBL6622 |
| ChEBI ID | 6061 |
| PubChem CID | 6883 |
| DrugBank | DB00883 |
| UNII ID | IA7306519N (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 7,589 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
11,075 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more